Research: Discontinuing anti-obesity drug tirzepatide leads to weight regain
New York, Dec 17, 2023.- The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within aContinuar Leyendo



















